University of Massachusetts - Amherst Partners With Spacelabs Healthcare To Advance Research And Innovation
Published: Sep 13, 2017
AMHERST, Mass. & SNOQUALMIE, Wash.--(BUSINESS WIRE)--The University of Massachusetts Amherst and Spacelabs Healthcare, a leading healthcare technology company, today announced a collaboration agreement with the shared mission of expanding medical technology and improving lives through value-based innovation.
Spanning clinical and technical areas, the UMass Amherst and Spacelabs collaboration agreement leverages the competencies of the two organizations to form an active partnership with academic, research and development, and commercial potential.
The collaboration agreement provides UMass nursing students access to new technologies to supplement their education, and expands clinical simulations for both the Amherst and Springfield campuses. In addition, UMass and Spacelabs will share resources for targeted initiatives supporting research, learning, and healthcare advancements.
“Spacelabs is extremely excited about the opportunities that exist with an outstanding academic institution such as UMass,” said Sujit Kumar, Spacelabs President. “Our rich histories, achievements, and commitment to excellence make this collaboration a true partnership.”
“Working with a passionate organization such as Spacelabs helps us combine academics and research to inspire unique possibilities for both faculty and students, and create innovative ways to improve patient health outcomes,” said Stephen Cavanagh, UMass Amherst College of Nursing Dean.
“We are delighted to make extensive Core Equipment Facilities, collaboratories and partnerships on human health-related research themes available to Spacelabs,” said Peter Reinhart, director of the Institute for Applied Life Sciences (IALS) at UMass Amherst.
The institute fosters a wide range of innovative programs in three centers, including the Center for Personalized Health Monitoring, providing interdisciplinary research, training, technology development and human validation testing. The Institute was in part funded center by a $95 million capital investment from the Massachusetts Life Sciences Center (MLSC).
About Spacelabs Healthcare, Inc. Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com), a subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology, and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, and Singapore and distributors in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to the Company's current expectations, beliefs, projections and similar expressions concerning matters that are not historical facts and are not guarantees of future performance. Forward-looking statements involve uncertainties, risks, assumptions and contingencies, many of which are outside the Company's control and which may cause actual results to differ materially from those described in or implied by any forward-looking statement. Such statements include, but are not limited to, statements regarding the performance of the Company’s products. For a further discussion of factors that could cause the Company's future results to differ materially from any forward-looking statements, see the section entitled "Risk Factors" in the OSI Systems, Inc. Annual Report on Form 10-K for the fiscal year ended June 30, 2017 and other risks described therein and in documents subsequently filed by OSI Systems, Inc. from time to time with the Securities and Exchange Commission. All forward-looking statements are based on currently available information and speak only as of the date on which they are made. The Company assumes no obligation to update any forward-looking statement made in this press release that becomes untrue because of subsequent events, new information or otherwise, except to the extent it is required to do so in connection with its ongoing requirements under federal securities laws.
Paul Sogge, 425-363-5592